Rigin 200mg (Palmitoyl Tetrapeptide-7) (Topical)

$200.00

Rigin 200mg (Palmitoyl Tetrapeptide-7) Topical is the synthetic palmitoylated tetrapeptide (Pal-Gly-Gln-Pro-Arg) derived from a tuftsin-related sequence. Characterised in cell-culture research for cytokine-modulation effects. Greater than 99 percent HPLC verified.

Category:

Peptide Science research editorial team.

Rigin 200mg (Palmitoyl Tetrapeptide-7) Topical Overview

Rigin 200mg (Palmitoyl Tetrapeptide-7) Topical from Peptide Science is the synthetic palmitoylated tetrapeptide with the sequence Pal-Gly-Gln-Pro-Arg, supplied as a topical research formulation for in-vitro dermal-cell and cytokine-pathway research. The compound is studied alongside Matrixyl and Syn-Coll in the multi-peptide signal-peptide subset of cosmetic-research material.

Compound Class and Mechanism

Rigin is the palmitoylated tetrapeptide derived from a tuftsin-related sequence, characterised in preclinical research for cytokine-modulation effects in cultured fibroblasts and keratinocytes. The compound has been documented for reduction of interleukin-6 and other inflammatory cytokine markers in cell-culture models. The palmitoyl conjugation provides lipophilic skin-cell penetration for topical-formulation research. Browse the broader cosmetic peptide range for related signal peptides studied in dermal-cell research.

Specifications

Rigin 200mg (Palmitoyl Tetrapeptide-7) Topical research specifications
Property Value
Compound Rigin (Palmitoyl Tetrapeptide-7, sequence Pal-Gly-Gln-Pro-Arg)
Class Synthetic palmitoylated tetrapeptide; anti-inflammatory cytokine-modulation signal peptide
Amino-acid count 4
Molecular weight approximately 695 g/mol
Source-protein basis Tuftsin-derived tetrapeptide (palmitoyl-conjugated immunomodulatory analog)
Supplied form Topical research formulation
Strength 200 mg per supply
Purity greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius; protect from light

For paired research with other palmitoylated cosmetic signal peptides, see Matrixyl 200mg Topical and Syn-Coll 200mg Topical.

Handling and Reconstitution

The topical research formulation is supplied for in-vitro cell-culture and animal-model dermatology work, not as a finished cosmetic product. The working concentration used in any given research protocol is set by the principal investigator. Aliquoting reconstituted stock for single-use storage is the standard handling practice for short signal peptides where repeated freeze-thaw cycles can affect activity.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is prepared in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in insulated, light-protected packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.

Reviews

There are no reviews yet.

Be the first to review “Rigin 200mg (Palmitoyl Tetrapeptide-7) (Topical)”

Your email address will not be published. Required fields are marked *

Scroll to Top